BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 9083473)

  • 1. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
    Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
    J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.
    Katz JL; Izenwasser S; Kline RH; Allen AC; Newman AH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):302-15. PubMed ID: 9862785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
    Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
    J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
    Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML
    J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
    Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
    Katz JL; Kopajtic TA; Agoston GE; Newman AH
    J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter.
    Newman AH; Izenwasser S; Robarge MJ; Kline RH
    J Med Chem; 1999 Sep; 42(18):3502-9. PubMed ID: 10479283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Carbomethoxy-3-(diarylmethoxy)-1 alpha H, 5 alpha H-tropane analogs: synthesis and inhibition of binding at the dopamine transporter and comparison with piperazines of the GBR series.
    Meltzer PC; Liang AY; Madras BK
    J Med Chem; 1996 Jan; 39(2):371-9. PubMed ID: 8558504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tropane-based irreversible ligands for the dopamine transporter.
    Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
    J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
    Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
    J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs.
    Campbell VC; Kopajtic TA; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Nov; 315(2):631-40. PubMed ID: 16055673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors.
    Newman AH; Kline RH; Allen AC; Izenwasser S; George C; Katz JL
    J Med Chem; 1995 Sep; 38(20):3933-40. PubMed ID: 7562926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
    Simoni D; Rossi M; Bertolasi V; Roberti M; Pizzirani D; Rondanin R; Baruchello R; Invidiata FP; Tolomeo M; Grimaudo S; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
    J Med Chem; 2005 May; 48(9):3337-43. PubMed ID: 15857139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.
    Carroll FI; Runyon SP; Abraham P; Navarro H; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Dec; 47(25):6401-9. PubMed ID: 15566309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
    J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.